To evaluate the therapeutic efficacy of anti-CEA scFab CAR-T cells against solid tumors, MB231/CEA breast tumors were orthotopically implanted in the mammary fat pads of immunocompromised NSG mice. Here, CEACAM5 is linked to breast neoplasm.